Soluble immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Ambarus, Carmen A ^a   Santegoets, Kim C M ^b   van Bon, Lenny ^b   Wenink, Mark H ^b   Tak, Paul P ^a   Radstake, Timothy R D J ^b   Baeten, Dominique L P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; CYTOKINE; IMMOBILIZED PROTEIN; LIGAND;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MONOCYTE; PHENOTYPE; POLARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CELL CULTURE; CHEMISTRY; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; TEMPERATURE;

MURINAE;

ANTIGEN-ANTIBODY COMPLEX; CELLS, CULTURED; CYTOKINES; GAMMA-GLOBULINS; HUMANS; IMMOBILIZED PROTEINS; IMMUNOGLOBULIN G; INTERLEUKIN-10; INTERLEUKIN-23; LIGANDS; LIPOPOLYSACCHARIDES; MACROPHAGES; PHENOTYPE; TEMPERATURE; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 84860376477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035994     Document Type: Article

References (57)

1. Bogdan C, Vodovotz Y, Nathan C, (1991) Macrophage deactivation by interleukin 10. J Exp Med 174: 1549-1555.
2. Goerdt S, Orfanos CE, (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137-142 S1074-7613(00)80014-X [pii].
3. Gordon S, (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35 10.1038/nri978 [doi];nri978 [pii].
4. Stein M, Keshav S, Harris N, Gordon S, (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292.
5. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686 S1471-4906(04)00295-9 [pii];10.1016/j.it.2004.09.015 [doi].
6. Mosser DM, (2003) The many faces of macrophage activation. J Leukoc Biol 73: 209-212.
7. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969 nri2448 [pii];10.1038/nri2448 [doi].
8. Ambarus CA, Krausz S, van Eijk M, Hamann J, Radstake TR, et al. (2011) Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods S0022-1759(11)00294-8 [pii];10.1016/j.jim.2011.10.013 [doi].
9. Bonney RJ, Naruns P, Davies P, Humes JL, (1979) Antigen-antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages. Prostaglandins 18: 605-616.
10. Gerber JS, Mosser DM, (2001) Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J Immunol 166: 6861-6868.
11. Sutterwala FS, Noel GJ, Clynes R, Mosser DM, (1997) Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 185: 1977-1985.
12. Sutterwala FS, Noel GJ, Salgame P, Mosser DM, (1998) Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med 188: 217-222.
13. Edwards JP, Zhang X, Frauwirth KA, Mosser DM, (2006) Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 80: 1298-1307 jlb.0406249 [pii];10.1189/jlb.0406249 [doi].
14. Anderson CF, Mosser DM, (2002) Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. J Immunol 168: 3697-3701.
15. Martinez FO, Sica A, Mantovani A, Locati M, (2008) Macrophage activation and polarization. Front Biosci 13: 453-461 2692 [pii].
16. Berger S, Ballo H, Stutte HJ, (1996) Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and anti-inflammatory cytokines dependent on the antigen:antibody ratio. Eur J Immunol 26: 1297-1301 10.1002/eji.1830260618 [doi].
17. Berger S, Chandra R, Ballo H, Hildenbrand R, Stutte HJ, (1997) Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur J Immunol 27: 2994-3000 10.1002/eji.1830271136 [doi].
18. Ronnelid J, Tejde A, Mathsson L, Nilsson-Ekdahl K, Nilsson B, (2003) Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann Rheum Dis 62: 37-42.
19. Abrahams VM, Cambridge G, Lydyard PM, Edwards JC, (2000) Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum 43: 608-616 10.1002/1529-0131(200003)43:3&608::AID-ANR18>3.0.CO;2-G [doi].
20. Debets JM, Van de Winkel JG, Ceuppens JL, Dieteren IE, Buurman WA, (1990) Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase. J Immunol 144: 1304-1310.
21. Herrmann F, De Vos S, Brach M, Riedel D, Lindemann A, et al. (1992) Secretion of granulocyte-macrophage colony-stimulating factor by human blood monocytes is stimulated by engagement of Fc gamma receptors type I by solid-phase immunoglobulins requiring high-affinity Fc-Fc gamma receptor type I interactions. Eur J Immunol 22: 1681-1685 10.1002/eji.1830220703 [doi].
22. Krutmann J, Kirnbauer R, Kock A, Schwarz T, Schopf E, et al. (1990) Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation. J Immunol 145: 1337-1342.
23. Mullazehi M, Mathsson L, Lampa J, Ronnelid J, (2006) Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis. Arthritis Rheum 54: 1759-1771 10.1002/art.21892 [doi].
24. Polat GL, Laufer J, Fabian I, Passwell JH, (1993) Cross-linking of monocyte plasma membrane Fc alpha, Fc gamma or mannose receptors induces TNF production. Immunology 80: 287-292.
25. Radstake TR, van Lent PL, Pesman GJ, Blom AB, Sweep FG, et al. (2004) High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering. Ann Rheum Dis 63: 696-702 10.1136/ard.2003.010033 [doi];63/6/696 [pii].
26. Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, et al. (2008) Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 58: 678-688 10.1002/art.23284 [doi].
27. Laurent L, Clavel C, Lemaire O, Anquetil F, Cornillet M, et al. (2011) Fcgamma receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins. Ann Rheum Dis 70: 1052-1059 ard.2010.142091 [pii];10.1136/ard.2010.142091 [doi].
28. Radstake TR, Blom AB, Sloetjes AW, van Gorselen EO, Pesman GJ, et al. (2004) Increased FcgammaRII expression and aberrant tumour necrosis factor alpha production by mature dendritic cells from patients with active rheumatoid arthritis. Ann Rheum Dis 63: 1556-1563 63/12/1556 [pii];10.1136/ard.2003.016550 [doi].
29. Anderson CF, Mosser DM, (2002) A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol 72: 101-106.
30. Landmann R, Knopf HP, Link S, Sansano S, Schumann R, et al. (1996) Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun 64: 1762-1769.
31. Gratchev A, Kzhyshkowska J, Kothe K, Muller-Molinet I, Kannookadan S, et al. (2006) Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 211: 473-486 S0171-2985(06)00076-3 [pii];10.1016/j.imbio.2006.05.017 [doi].
32. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, et al. (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 101: 4560-4565 10.1073/pnas.0400983101 [doi];0400983101 [pii].
33. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH, (2006) Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol 79: 285-293 jlb.0105015 [pii];10.1189/jlb.0105015 [doi].
34. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA, (1995) Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J Immunol 154: 3454-3460.
35. Virgin HW, Unanue ER, (1984) Immune complexes suppress cellular immunity. Ann N Y Acad Sci 437: 16-27.
36. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD, (2007) Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 178: 5245-5252 178/8/5245 [pii].
37. Wijngaarden S, Van de Winkel JG, Jacobs KM, Bijlsma JW, Lafeber FP, et al. (2004) A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis. Arthritis Rheum 50: 3878-3887 10.1002/art.20672 [doi].
38. Tripp CS, Beckerman KP, Unanue ER, (1995) Immune complexes inhibit antimicrobial responses through interleukin-10 production. Effects in severe combined immunodeficient mice during Listeria infection. J Clin Invest 95: 1628-1634 10.1172/JCI117837 [doi].
39. Chroneos Z, Shepherd VL, (1995) Differential regulation of the mannose and SP-A receptors on macrophages. Am J Physiol 269: L721-L726.
40. Hogger P, Dreier J, Droste A, Buck F, Sorg C, (1998) Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 161: 1883-1890.
41. Koning N, van Eijk M, Pouwels W, Brouwer MS, Voehringer D, et al. (2010) Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation. J Innate Immun 2: 195-200 000252803 [pii];10.1159/000252803 [doi].
42. Mathsson L, Lampa J, Mullazehi M, Ronnelid J, (2006) Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells. Arthritis Res Ther 8: R64 ar1926 [pii];10.1186/ar1926 [doi].
43. Ravetch JV, Bolland S, (2001) IgG Fc receptors. Annu Rev Immunol 19: 275-290 19/1/275 [pii];10.1146/annurev.immunol.19.1.275 [doi].
44. Wenink MH, Santegoets KC, Roelofs MF, Huijbens R, Koenen HJ, et al. (2009) The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease. J Immunol 183: 4509-4520 jimmunol.0900153 [pii];10.4049/jimmunol.0900153 [doi].
45. Wernersson S, Karlsson MC, Dahlstrom J, Mattsson R, Verbeek JS, et al. (1999) IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice. J Immunol 163: 618-622 ji_v163n2p618 [pii].
46. Kim JW, Wierda WG, Kim YB, (1991) Immobilized IgG immune complex induces secretion of tumor necrosis factor-alpha by porcine alveolar macrophages. Am J Respir Cell Mol Biol 5: 249-255.
47. Gupta S, Booth JW, (2010) ERK phosphorylation and tumor necrosis factor-alpha production by monocytes are persistent in response to immobilized IgG. Biochem Biophys Res Commun 402: 301-304 S0006-291X(10)01871-1 [pii];10.1016/j.bbrc.2010.10.020 [doi].
48. DiMartino SJ, Yuan W, Redecha P, Ivashkiv LB, Salmon JE, (2008) Insoluble immune complexes are most effective at triggering IL-10 production in human monocytes and synergize with TLR ligands and C5a. Clin Immunol 127: 56-65 S1521-6616(07)01413-1 [pii];10.1016/j.clim.2007.11.014 [doi].
49. Boross P, Verbeek JS, (2006) The complex role of Fcgamma receptors in the pathology of arthritis. Springer Semin Immunopathol 28: 339-350 10.1007/s00281-006-0049-9 [doi].
50. Ji JD, Tassiulas I, Park-Min KH, Aydin A, Mecklenbrauker I, et al. (2003) Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J Exp Med 197: 1573-1583 10.1084/jem.20021820 [doi];jem.20021820 [pii].
51. Yuan W, DiMartino SJ, Redecha PB, Ivashkiv LB, Salmon JE, (2011) Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes. Arthritis Rheum 63: 212-218 10.1002/art.30083 [doi].
52. Ballow M, (2011) The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 127: 315-323 S0091-6749(10)01645-3 [pii];10.1016/j.jaci.2010.10.030 [doi].
53. Ephrem A, Misra N, Hassan G, Dasgupta S, Delignat S, et al. (2005) Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin. Clin Exp Med 5: 135-140 10.1007/s10238-005-0079-y [doi].
54. Nimmerjahn F, Ravetch JV, (2007) Fc-receptors as regulators of immunity. Adv Immunol 96: 179-204 S0065-2776(07)96005-8 [pii];10.1016/S0065-2776(07)96005-8 [doi].
55. Nimmerjahn F, Ravetch JV, (2007) The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med 204: 11-15 jem.20061788 [pii];10.1084/jem.20061788 [doi].
56. Vos AC, Wildenberg ME, Duijvestein M, Verhaar AP, van den Brink GR, et al. (2011) Anti-tumor necrosis factor-alpha antibodies induce regulatory macrophages in an Fc region-dependent manner. Gastroenterology 140: 221-230 S0016-5085(10)01496-4 [pii];10.1053/j.gastro.2010.10.008 [doi].
57. Vos AC, Wildenberg ME, Arijs I, Duijvestein M, Verhaar AP, et al. (2011) Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro. Inflamm Bowel Dis 10.1002/ibd.21818 [doi].